Literature DB >> 20196803

Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver.

M C Ryan1, P V Desmond, J L Slavin, M Congiu.   

Abstract

Hepatitis C virus (HCV) infection is frequently associated with hepatic steatosis, particularly in patients with HCV genotype-3 (HCVGT3). It has variously been hypothesized, largely from in-vitro studies, to be the result of increased synthesis, decreased metabolism and export of triglycerides. We measured by real-time PCR the expression of genes involved in lipid metabolism [acetyl-Coenzyme A carboxylase alpha, apolipoprotein B (APOB), diacylglycerol O-acyltransferase 2, fatty acid-binding protein 1, fatty acid synthase, microsomal triglyceride transfer protein (MTTP), peroxisome proliferator-activated receptor alpha (PPARA), peroxisome proliferator-activated receptor gamma (PPARG), protein kinase AMP-activated alpha 1 catalytic subunit (PRKAA1) and sterol regulatory element-binding transcription factor 1 (SREBF1)] in liver biopsies from patients infected with HCV genotype-1 (HCVGT1), HCVGT3 and Hepatitis B (HBV) using β-glucuronidase (GUSB) and splicing factor arginine/serine-rich 4 (SFRS4) as housekeeping genes. Patients infected with HCVGT3 were younger than those infected with HCVGT1 (36.3 ± 2.5 vs 45.6 ± 1.5, P < 0.05, Mann-Whitney) and were more likely to have steatosis (69.2%vs 11.8%). No significant difference was found in the expression of genes involved in lipogenesis or transport in patients infected with HBV or HCV of either genotype. Contrary to expectation, given the greater degree of steatosis in HCVGT3-infected liver, expression of enzymes involved in lipogenesis was not elevated in HCVGT3 compared with HCVGT1 or HBV-infected liver. Significantly less mRNA for SREBF1 was found in HCVGT3-infected liver tissue compared with HCVGT1-infected liver (1.00 ± 0.06 vs 0.70 ± 0.15 P < 0.05). These results suggest that steatosis in patients infected with HCVGT3 is not the result of a sustained SREBF1 driven increase in expression of genes involved in lipogenesis. In addition, a significant genotype-independent correlation was found between the expression of APOB, MTTP, PRKAA1 and PPARA, indicating that these networks are functional in HCV-infected liver.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20196803     DOI: 10.1111/j.1365-2893.2010.01283.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  7 in total

Review 1.  Chaperones in hepatitis C virus infection.

Authors:  Ronik Khachatoorian; Samuel W French
Journal:  World J Hepatol       Date:  2016-01-08

2.  Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections.

Authors:  Tapas Patra; Reina Sasaki; Keith Meyer; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

3.  Prediction of Cirrhosis in Patients with Chronic Hepatitis C by Genotype 3.

Authors:  Tarana Gupta; Hari K Aggarwal; Sandeep Goyal; Virendra Singh
Journal:  Euroasian J Hepatogastroenterol       Date:  2020 Jan-Jun

Review 4.  Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.

Authors:  Amedeo Lonardo; Luigi Elio Adinolfi; Luciano Restivo; Stefano Ballestri; Dante Romagnoli; Enrica Baldelli; Fabio Nascimbeni; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

5.  Viral sequence variation in chronic carriers of hepatitis C virus has a low impact on liver steatosis.

Authors:  Marion Depla; Louis d'Alteroche; Amélie Le Gouge; Alain Moreau; Christophe Hourioux; Jean-Christophe Meunier; Julien Gaillard; Anne de Muret; Yannick Bacq; Farhad Kazemi; Aurélie Avargues; Emmanuelle Roch; Eric Piver; Catherine Gaudy-Graffin; Bruno Giraudeau; Philippe Roingeard
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

6.  Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected Liver.

Authors:  W M H d'Avigdor; M A Budzinska; M Lee; R Lam; J Kench; M Stapelberg; S V McLennan; G Farrell; J George; G W McCaughan; T Tu; N A Shackel
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

7.  Lysophosphatidylethanolamine Affects Lipid Accumulation and Metabolism in a Human Liver-Derived Cell Line.

Authors:  Yusuke Yamamoto; Toshihiro Sakurai; Zhen Chen; Nao Inoue; Hitoshi Chiba; Shu-Ping Hui
Journal:  Nutrients       Date:  2022-01-28       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.